• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 32 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1112
Limosilactobacillus reuteri strain ATCC PTA-126787 and L. reuteri strain ATCC PTA-126788, in combination, on a 1:1 ratio of colony forming unit (CFU) basis Pending
  1094
Saccharomyces cerevisiae strain BY-989 expressing a gene encoding a carbon-sulfur lyase from Citrobacter freundii Pending
  1064
Pomegranate extract Pending
  1053
6'-sialyllactose sodium salt May 12, 2023 FDA Has No Questions (in PDF) (266 kB)
  987
2'-fucosyllactose Feb 2, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
  908
Lipase from Penicillium camemberti Feb 5, 2021 FDA has no questions (in PDF) (184 kB)
  866
Lipase from Penicillium camemberti Feb 5, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (257 kB)
  812
Rebaudioside M Dec 8, 2018 FDA has no questions (in PDF) (659 kB)
  743
β-galactosidase from Papiliotrema terrestris Jun 1, 2018 FDA has no questions (in PDF) (68 kB)
  623
Fructooligosaccharides Aug 1, 2016 FDA has no questions
  620
Galacto-oligosaccharides Jul 21, 2016 FDA has no questions
  612
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 May 19, 2016 At the notifier's request, FDA ceased to evaluate this notice
  611
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 Apr 15, 2016 At the notifier's request, FDA ceased to evaluate this notice
  460
Curcuminoids purified from turmeric (Curcuma longa L.) Aug 23, 2013 FDA has no questions; some uses may require a color additive listing
  444
Milk protein concentrate and milk protein isolate Mar 18, 2013 At the notifier's request, FDA ceased to evaluate this notice
  504
  442
Volatile oil of mustard (white) Jan 3, 2013 At the notifier's request, FDA ceased to evaluate this notice
  426
Rice hull fiber May 29, 2012 At the notifier's request, FDA ceased to evaluate this notice
  376
Milk mineral concentrate Oct 11, 2011 FDA has no questions
  267
Protein glutaminase enzyme preparation derived from Chryseobacterium proteolyticum Jul 15, 2009 FDA has no questions
  247
Modified gum acacia Oct 7, 2008 FDA has no questions
  216
Lipase enzyme preparation from Rhizopus oryzae May 18, 2007 FDA has no questions
  175
Saccharomyces cerevisiae strain ECMo01 with enhanced expression of urea amidolyase Jan 6, 2006 FDA has no questions
  174
Lysozyme (human) enzyme preparation from rice Sep 13, 2005 At the notifier's request, FDA ceased to evaluate this notice
  127
Spirulina, the dried biomass of Arthrospira platensis
   (Resubmission of GRN 101)
Oct 6, 2003 FDA has no questions; some uses may require a color additive listing
  101
Spirulina May 28, 2002 At the notifier's request, FDA ceased to evaluate this notice
  127
  88
Invertase enzyme preparation from Saccharomyces cerevisiae and lactase enzyme preparation from Kluyveromyces marxianus Apr 3, 2002 FDA has no questions
  87
Composite filtration media (diatomaceous earth and perlite) Feb 26, 2002 FDA has no questions
  86
Coagulated potato protein, hydrolyzed potato protein, or clarified hydrolyzed potato protein Apr 3, 2002 FDA has no questions
  85
Isoamylase from Pseudomonas amyloderamosa Feb 19, 2002 FDA has no questions
  81
Lipase from Candida rugosa Feb 7, 2002 FDA has no questions
  68
Lipase from Penicillium camembertii May 29, 2001 FDA has no questions
  22
alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding a modified alpha-amylase derived from Bacillus lichenformis and Bacillus amyloliquefaciens Dec 29, 1999 FDA has no questions

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-